71 results match your criteria: "Department of Internal Medicine. University of Texas Southwestern Medical Center[Affiliation]"

Hairy cell leukemia is an uncommon B-cell malignancy with excellent response to purine analogs and to targeted therapies such as ibrutinib and vemurafenib. However, purine analogs are known to be highly immunosuppressive and the infection burden in this patient population with current therapies is unknown. We therefore conducted a retrospective cohort study following 149 patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how people's bodies respond during three different exercise tests for those who have unexplained breathlessness.
  • These tests were the treadmill cardiopulmonary exercise test (CPX), the 6-minute walk test (6MWT), and the timed up and go test (TUGT).
  • The results showed that the CPX caused the biggest changes in heart rate and breathing, while the 6MWT and TUGT showed smaller responses, but the TUGT still increased physical responses even though it was shorter.
View Article and Find Full Text PDF

Background: Prematurely born adults have increased risk for cardiovascular disease. There are limited cardiac data on US-born preterm individuals. We aimed to determine whether adolescents and adults born prematurely have altered left ventricular (LV) structure and function, and to interrogate diastolic function using isometric handgrip exercise.

View Article and Find Full Text PDF

Background: There are no shared decision-making frameworks for selecting blood pressure (BP) targets for individuals with hypertension. This study addressed whether results from the SPRINT (Systolic Blood Pressure Intervention Trial) could be tailored to individuals using predicted risks and simulated preferences.

Methods And Results: Among 8202 SPRINT participants, Cox models were developed and internally validated to predict each individual's absolute difference in risk from intensive versus standard BP lowering for cardiovascular events, cognitive impairment, death, and serious adverse events (AEs).

View Article and Find Full Text PDF

Following the publication of results from multiple landmark cardiovascular outcome trials of antihyperglycemic medications over the past 8 years, there has been a major shift in the focus of care for people with type 2 diabetes, from control of hyperglycemia to managing cardiovascular risk. Multiple international cardiology and diabetes society guidelines and recommendations now endorse sodium-glucose cotransporter-2 inhibitors and glucagon-like protein-1 receptor agonists as first-line therapies to mitigate cardiovascular risk. The most recent publication is the 2023 European Society of Cardiology guideline on the management of cardiovascular disease in those with type 2 diabetes that, for the first time, recommends use of both classes of medications for the mitigation of cardiovascular risk for those with or at high risk for atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease.

View Article and Find Full Text PDF

Background: High-sensitivity troponin I (hs-cTnI) and T (hs-cTnT) provide complementary information regarding cardiovascular disease risk. The explanation for their distinct risk profiles is incompletely understood.

Methods And Results: hs-cTnI and hs-cTnT were measured in Dallas Heart Study participants.

View Article and Find Full Text PDF

Objective: Excess adiposity represents a risk factor for chronic kidney disease (CKD) and progression to end-stage kidney disease. Anti-Obesity Medications (AOMs) are vastly underutilized in patients with advanced CKD because of concerns related to safety and efficacy. This study was conducted to evaluate the real-world approach to weight management and the efficacy and safety of AOMs in people with advanced CKD.

View Article and Find Full Text PDF

Background: Among individuals with hypertension and low diastolic blood pressure (DBP), the optimal BP target remains controversial due to concerns that BP lowering may reduce coronary perfusion. We determined the impact of intensive BP control among individuals with elevated systolic BP who have low DBP and elevated hs-cTnT (high-sensitivity cardiac troponin T) levels.

Methods And Results: A total of 8828 participants in SPRINT (Systolic Blood Pressure Intervention Trial) were stratified by baseline DBP.

View Article and Find Full Text PDF

Human peri-gastruloids: a significant advancement in embryology research.

MedComm (2020)

January 2024

Key Laboratory of Birth Defects and Related Diseases of Women and Children Department of Paediatrics West China Second University Hospital, State Key Laboratory of Biotherapy Sichuan University Chengdu China.

The peri-gastruloids comprise both embryonic (epiblast) and extraembryonic (hypoblast) tissues, faithfully mirroring crucial developmental events spanning from the immediate post-implantation phase to early organogenesis, encompassing the emergence of amniotic and yolk sac cavities, as well as the progression from bilaminar to trilaminar embryonic discs.

View Article and Find Full Text PDF

A group of gene mutations has been identified to be strongly associated with secondary acute myeloid leukemias (AML) arising from prior myeloid neoplasms. The International Consensus Classification (ICC) and proposed 5th edition of the World Health Organization (WHO) classification differ by inclusion of . A recent study suggested that having two or more secondary mutations is associated with a particularly poor prognosis.

View Article and Find Full Text PDF
Article Synopsis
  • Prevention strategies for standard modifiable cardiovascular risk factors (SMuRFs) are crucial for improving outcomes in cardiovascular disease, but acute myocardial infarction (AMI) can still occur in individuals without SMuRFs.
  • A study analyzed AMI hospitalizations from 2000 to 2014 and found that 3.6% of patients had no documented SMuRFs, often receiving fewer medical treatments and procedures.
  • Patients without SMuRFs had significantly higher mortality rates within 28 days and 1 year after hospitalization for AMI compared to those with SMuRFs, highlighting the need for better early risk identification and tailored treatment strategies for this group.
View Article and Find Full Text PDF

Background To date, assessment of right ventricular (RV) function in mice has relied extensively on invasive measurements. Echocardiographic advances have allowed adaptation of measures used in humans for serial, noninvasive RV functional assessment in mice. We evaluated the diagnostic performance of tricuspid annular plane systolic excursion (TAPSE), RV peak systolic myocardial velocity (s'), RV myocardial performance index (MPI), and RV fractional area change (FAC) in a mouse model of pulmonary hypertension.

View Article and Find Full Text PDF

Introduction: Texas Health Resources (THR), a large, nonprofit health care system based in the Dallas-Fort Worth area, has collaborated with the University of Texas Southwestern Medical Center (UTSW) to develop and operate a unique, integrated approach for Learning Health System (LHS) workforce development. This training model centers on academic health system faculty members conducting later-stage translational research within a partnering regional care delivery organization.

Methods: The THR Clinical Scholars Program engages early career UTSW faculty members to conduct studies that are likely to have an impact on care delivery at the health system level.

View Article and Find Full Text PDF

Background We showed that Beclin-1-dependent autophagy protects the heart in young and adult mice that underwent endotoxemia. Herein, we compared the potential therapeutic effects of Beclin-1 activating peptide, TB-peptide, on endotoxemia-induced cardiac outcomes in young adult and aged mice. We further evaluated lipopolysaccharide (lipopolysaccharide)-induced and TB-peptide treatment-mediated alterations in myocardial metabolism.

View Article and Find Full Text PDF

Erythropoietin-stimulating agents (ESAs) have revolutionized anemia treatment in end-stage renal disease (ESRD), but ESA resistance is increasingly identified. Secondary hyperparathyroidism (SHP) is one cause of ESA resistance. We describe a patient with ESA-resistant, transfusion-dependent anemia and mild SHP with remodeling and reticulin fibrosis on bone marrow biopsy, all of which resolved with stricter SHP management.

View Article and Find Full Text PDF

Background: Acute generalized exanthematous pustulosis (AGEP) is a severe pustular drug eruption with rare reports of haemodynamic instability.

Objective: To describe the clinical characteristics, management, and outcomes of patients with AGEP-associated haemodynamic instability.

Methods: This retrospective case series identified adult patients diagnosed with AGEP who had haemodynamic instability from November 2012 to February 2020 that were seen at two academic teaching hospitals with roles as a burn centre and tertiary referral centre at the University of Texas Southwestern Medical Center in Dallas, TX USA.

View Article and Find Full Text PDF
Article Synopsis
  • The WATCH-DM and TRS-HF risk scores were created to predict heart failure risk specifically in individuals with type 2 diabetes, with WATCH-DM focusing on predicting new heart failure events and TRS-HF on hospitalizations due to heart failure.
  • In a study analyzing two clinical trial cohorts (TECOS and Look AHEAD) and a health record cohort, both risk scores demonstrated similar performance in predicting five-year heart failure risk, particularly in the Look AHEAD cohort.
  • However, there were significant differences in performance, with lower predictive accuracy found in the TECOS cohort, where both scores underpredicted the risk of heart failure events.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed data from over 15,000 COVID-19 hospitalizations and found that only 54 patients (0.35%) had in-hospital STEMI; most underwent echocardiography but only half had coronary angiography, and many did not receive timely treatment.
  • Patients with COVID-19 and STEMI faced significantly worse outcomes, including higher rates of shock, cardiac arrest, heart failure, and in-hospital death (41% with STEMI compared to 16% without), highlighting the need for improved treatment protocols
View Article and Find Full Text PDF